Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-314-6 | CAS number: 1469983-39-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 oral rat > 2000 mg/Kg bw
LD50 dermal rat > 2000 mg/Kg bw
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- From June 7,2012 to June 29,2012
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant with international guideline
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Italy
- Age at study initiation:6-7 weeks old
- Weight at study initiation: 150 to 174 g
- Fasting period before study: overnight fast prior to dosing and a period of approximately 4 hours after dosing.
- Housing: 5 of one sex to a cage, in polisulphone solid bottomed cages measuring 59 x 38.5 x 20 cm.
- Diet: A commercially available laboratory rodent diet (4RF18, Mucedola S.r.l) will be offered ad libitum throughout the study.
- Water : Drinking water will be supplied ad libitum to each cage via water bottles
- Acclimation period: 5 days
- Health check: yes
- Water content: 15%
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C ± 2°C
- Humidity (%): 55% ± 15%
- Air changes (per hr):15 to 20 air changes per hour
- Photoperiod (hrs dark / hrs light):12 hours cycle dark/light - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 10 ml/kg w - Doses:
- 5, 50, 300, 2000 mg/kg bw (based on active ingredient)
- No. of animals per sex per dose:
- 4 females x doses
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: twice daily
- Sings: Animals will be examined for signs of reaction to treatment on dosing, approximately 30 minutes, 2 and 4 hours after dosing on Day 1, then at least once daily for a total of 14 days.
- Body weight: Each animal will be weighed on the day of allocation to study, on the day of dosing (Day 1) and on Days 2, 8 and 15. Animals dying dur ing the study will be weighed at the time of death or when found.
- Necropsy of survivors performed: yes, Necropsy was carried out on all animals, (gross necropsy examination for both external and internal abnor malities, with particular attention to the gastro-intestinal tract). All abnormalities were recorded.
Animals in extremis and those that have completed the scheduled test period will be killed with carbon dioxide.
- Other examinations performed: gross examination including the opening of the cranial, thoracic and abdominal cavities and the examination of the major organs. The stomach and representative sections of the gastro-intestinal tract will be opened for examination. - Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- no mortality observed
- Clinical signs:
- other: Four additional female animals were treated at 2000 mg/kg. No mortality was observed in the main study. No clinical signs were noted during the observation period in 3 out of 4 animals treated. In the fourth animal (no. 91080023) clinical signs such as sa
- Gross pathology:
- No abnormalities were observed at the necropsy examination performed on termination of the observation period in the sighting study animal and in 3 out of 4 animals of the main study (those who did not show clinical signs). In the remaining animal of the main study, swollen abdomen was noted and at the internal examination, gas content and swelling were observed in the stomach, duodenum, jejunum, ileum, caecum and colon.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The results indicate that the test item, has no toxic effect on the rat following oral administration of single doses of 2000 mg/kg. The lack of mortality demonstrates the LD50 to be greater than 2000 mg/kg body weight.
- Executive summary:
The acute toxicity of Paraffin waxes and Hydrocarbon waxes C14-17, chloro, sulfochlorinated, low sulphonated, saponified was investigated following a single oral administration (10 mL/kg in corn oil) to the Sprague Dawley rat followed by a 14-day observation period. A sighting study was performed in which a single female animal was dosed at 2000 mg/kg. No mortality and no clinical signs were seen during the observation period. A main study was then performed on an additional 4 females which were dosed at 2000 mg/kg. No mortality occurred. No clinical signs considered related to the toxicity of the test item were noted during the observation period. The body weight changes observed in the animals were not remarkable with the exception of body weight loss observed in a single animal showing signs that could be unrelated to the toxicity of the test item. All animals were killed at the end of the observation period and subjected to necropsy examination. No abnormalities were observed at the necropsy examination performed on termination of the observation period in 4 out of 5 animals treated. In the remaining animal, swollen abdomen, gas content and swelling were observed in the gastrointestinal tract. These results indicate that the test item,
Paraffin waxes and Hydrocarbon waxes C14-17, chloro, sulfochlorinated, low sulphonated, saponified, has no toxic effect on the rat following oral administration of single doses of 2000 mg/kg. The lack of mortality demonstrates the LD50 to be greater than 2000 mg/kg body weight.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Good GLP study available on a similar substance
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Good GLP study available on a similar substance
Additional information
Two good GLP studies are available on a very similar substance, and both agreed in not showing any clinical sign and any toxicity at doses of 2000 mg/Kg bw for oral and dermal routes.
It can be assumed that the results will be the same also for Paraffin waxes and Hydrocarbon waxes, chloro, sulfochlorinated, saponified. Molecular weight will be usually higher or sulphonation degree, then hydrophylicity and/or salification proportions higher, leading to a better toxicological profile
Justification for selection of acute toxicity – oral endpoint
Study conducted on Paraffin waxes and Hydrocarbon waxes C14-17, chloro, sulfochlorinated, low sulphonated, saponified and has been used as read across for Paraffin waxes and Hydrocarbon waxes, chloro, sulfochlorinated, saponified. This study is conducted in accordance with GLP compliance with international guideline
Justification for selection of acute toxicity – dermal endpoint
Study conducted on Paraffin waxes and Hydrocarbon waxes C14-17, chloro, sulfochlorinated, low sulphonated, saponified and has been used as read across for Paraffin waxes and Hydrocarbon waxes, chloro, sulfochlorinated, saponified. This study is conducted in accordance with GLP compliance with international guideline
Justification for classification or non-classification
Substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria shown in Table 3.1.1 of CLP Regulation. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE). The limit value that can trigger to Classification is 2000 mg/Kg both for oral and dermal exposure pattern
No classification for acute toxicity oral is warranted under Regulation 1272/2008
No classification for acute toxicity dermal is warranted under Regulation 1272/2008
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.